Print | PDF | Email Page

Life Sciences M&A

Jones Day’s M&A attorneys understand the business needs of pharmaceutical, medical device, and biotechnology companies. Working in collaboration with lawyers in the Firm’s Life Sciences Practice, our M&A lawyers apply their strategic skills and experience to develop novel ways to address the multidisciplinary challenges that arise in life sciences transactions. This combination of legal disciplines in a multi-jurisdictional approach maximizes value for our clients, from start-up, venture backed, or private equity owned companies, to the world’s largest pharmaceutical and medical device companies. 

Jones Day’s M&A lawyers structure and negotiate domestic and cross-border transactions involving products at all lifecycle stages - from discovery, development, and clinical testing to sale and promotion. These transactions routinely include public and private mergers, stock or asset acquisitions, spin-offs, joint ventures, strategic alliances, and other collaborative arrangements.
Featured Experience
Jonn R. Beeson
Bruce W. Raphael
Kevin B. Espinola
Charles Gavoty